After extended discussions, the ASMS Board has decided to postpone the 2021 annual conference from June to late October. This difficult decision was made to provide the best possible opportunity to gather face-to-face in 2021. While the 2020 virtual meeting (Reboot) was a success on several fronts, the organizers recognized that many of the critical elements of the traditional annual conference were less effective in a virtual format, notably poster sessions and exhibits.
The organizers are optimistic that the postponed meeting will take place in person at the Pennsylvania Convention Center, Philadelphia, USA, and will mark a return to the annual conference that scientists expect and enjoy. The 2022 annual conference and beyond will remain in the traditional June timeframe.
The new dates for the 69th ASMS Conference on Mass Spectrometry and Allied Topics are October 31 – November 4, 2021. The short courses are October 30–31, 2021. Abstract submission will open on May 1.
For more information, please visit: www.asms.org.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.